Iovance Biotherapeutics IOVA 深 沪
等待开盘 03-31 09:30:00 美东时间
3.32
-0.190
-5.41%
华盛通- 最 高3.51
- 今 开3.51
- 成交量 993.14万股
- 最 低 3.26
- 昨 收 3.51
- 总市值 13.68亿
- 52周最高 5.63
- 市盈率 静 --
- 换手率 2.41%
- 52周最低 1.6385
- 委 比 82.24%
- 总股本 4.12亿
- 历史最高 54.208
- 量 比 1.05
- 振 幅 7.12%
- 历史最低 1.6385
- 每 手 1
- 风险率 0.68%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Iovance Biotherapeutics granted stock options for 3,400 shares to a new non-executive employee under its Amended 2021 Inducement Plan. Each option has an exercise price of $3.87 and vests over three years. The company focuses on innovative TIL therapies, with Amtagvi® being the first FDA-approved T-cell therapy for solid tumors.
03-20 21:15
美股周涨跌榜 | 与诺和诺德“世纪大和解”！Hims周内暴涨超57%；PayPay上市两日涨超32%
与诺和诺德“世纪大和解”！Hims周内暴涨超57%；近十年日企赴美最大IPO，PayPay上市两日涨超32%；获英伟达20亿美元投资，Nebius周涨超26%>>
03-14 10:29
美股周涨跌榜 | DAWN周涨一倍，获国际制药集团Servier溢价收购；Ziff Davis周涨56.3%
DAWN周涨一倍，获国际制药集团Servier溢价收购；Ziff Davis周涨56.3%，将其下属部门出售给埃森哲，获巴克莱上调其目标价；TNGX周涨52.1%，Q4亏损同比收窄超预期>>
03-07 10:50
What's Going On With Iovance Biotherapeutics Stock On Friday?
Iovance stock jumps despite no news as investors watch short interest and promising early data from its cancer therapy trial.
03-07 02:06
美股大行评级 | 最高582美元！博通获多家机构上调目标价；GENI、Okta、Rigetti Computing、Veeva Systems、Wix.com遭多家机构下调目标价
今日重点评级关注：韦德布什：维持TScan Therapeutics"跑赢大市"评级，目标价从4美元升至5美元；HC Wainwright & Co.：维持莱斯康制药"买入"评级，目标价从4美元升至6美元
03-06 11:58
UBS Maintains Neutral on Iovance Biotherapeutics, Raises Price Target to $4
UBS analyst David Dai maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Neutral and raises the price target from $2 to $4.
03-05 23:04
Iovance Biotherapeutics Signals Strong Momentum In Earnings
Iovance Biotherapeutics (($IOVA)) has held its Q4 earnings call. Read on for th...
03-04 08:25
美股大行评级 | 大摩将应用材料目标价升至432美元；潜在涨幅200.0%！维尔生物科技获巴克莱升目标价至30美元，维持"超配"评级
今日重点评级关注：巴克莱：维持Vir Biotechnology"超配"评级，目标价从26美元升至30美元；巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从10美元升至11美元
02-26 09:30
This Oracle Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a comple...
02-25 22:41
Citizens Upgrades Iovance Biotherapeutics to Market Outperform, Announces $5 Price Target
Citizens analyst Reni J. Benjamin upgrades Iovance Biotherapeutics (NASDAQ:IOVA) from Market Perform to Market Outperform and announces $5 price target.
02-25 20:15
